Posts tagged: therapies
Research Highlights New Treatments, Compares Existing Therapies For Prostate Cancer
Research on promising new therapies and data on the relative benefits of established treatments for prostate cancer have been released, in advance of the fourth annual Genitourinary Cancers Symposium, being held February 2-4, 2012, at the San Francisco Marriott Marquis in San Francisco, Calif...
TGen, UA receive NFCR grant to study targeted pancreatic cancer therapies
The Translational Genomics Research Institute (TGen) and the University of Arizona (UA) have received a three-year, $600,000 grant to study targeted cancer therapies from the National Foundation for Cancer Research.
Research from the 2012 Genitourinary Cancers Symposium highlights new treatments, compares existing therapies for prostate cancer
ALEXANDRIA, Va. Research on promising new therapies and data on the relative benefits of established treatments for prostate cancer were released today, in advance of the fourth annual Genitourinary Cancers Symposium, being held February 2-4, 2012, at the San Francisco Marriott Marquis in San Francisco, Calif. ...
Research from the 2012 Genitourinary Cancers Symposium highlights new treatments, compares existing therapies for prostate cancer
(American Society of Clinical Oncology) Research on promising new therapies and data on the relative benefits of established treatments for prostate cancer were released today, in advance of the fourth annual Genitourinary Cancers Symposium, being held Feb. 2-4, 2012, at the San Francisco Marriott Marquis in San Francisco, Calif.
Collaborative research sheds light on new cancer stem cell therapies
A collaborative anti-cancer research jointly conducted by The Hong Kong Polytechnic University (PolyU), Peking University Shenzhen Graduate School and Nevada Cancer Institute has led to the development of a novel class of chemical inhibitors that specifically target cancer cells with pluripotency.
Enzyme Function Could Help Find Muscular Dystrophy Therapies
Study reveals function of glycosylating enzyme involved in muscular dystrophy, brain development and infection by arenaviruses such as Lassa fever; ability to assay enzyme activity could help screen potential muscular dystrophy therapies Researchers at the University of Iowa have worked out the exact function of an enzyme that is critical ...
The Effectiveness Of Nicotine Replacement Therapies In Doubt
Nicotine replacement therapies (NRTs) designed to help people stop smoking, specifically nicotine patches and nicotine gum, do not appear to be effective in helping smokers quit long-term, even when combined with smoking cessation counseling, according to a new study by researchers at Harvard School of Public Health (HSPH) and the ...
Survival In Brain Cancer Patients May Be Improved By Personalized Gene Therapies
Personalized prognostic tools and gene-based therapies may improve the survival and quality of life of patients suffering from glioblastoma, an aggressive and deadly form of brain cancer, reports a new University of Illinois study funded by the NIH National Cancer Institute. "We confirmed known biomarkers of glioblastoma survival and discovered ...
Personalized therapies may improve survival and QoL of patients with glioblastoma
Personalized prognostic tools and gene-based therapies may improve the survival and quality of life of patients suffering from glioblastoma, an aggressive and deadly form of brain cancer, reports a new University of Illinois study funded by the NIH National Cancer Institute.
Study reveals enzyme function, could help find muscular dystrophy therapies
Researchers at the University of Iowa have worked out the exact function of an enzyme that is critical for normal muscle structure and is involved in several muscular dystrophies. The findings, which were published Jan. 6 in the journal Science , could be used to develop rapid, large-scale testing ...
Personalized gene therapies may increase survival in brain cancer patients
Personalized prognostic tools and gene-based therapies may improve the survival and quality of life of patients suffering from glioblastoma, an aggressive and deadly form of brain cancer, reports a new University of Illinois study funded by the NIH National Cancer Institute. "We confirmed known biomarkers of glioblastoma ...